Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2022 | A Chunking-for-Pooling Strategy for Cytometric Representation Learning for Automatic Hematologic Malignancy Classification | Li, Jeng-Lin; Lin, Yun-Chun; Wang, Yu-Fen; Monaghan, Sara A; BOR-SHENG KO ; Lee, Chi-Chun | IEEE journal of biomedical and health informatics | 0 | 0 | |
2013 | Clinical and Microbiological Characteristics of Perianal Infections in Adult Patients with Acute Leukemia | Chen, Chien-Yuan ; ARISTINE CHENG ; SHANG-YI HUANG ; WANG-HUEI SHENG ; JIA-HAU LIU ; BOR-SHENG KO ; MING YAO ; WEN-CHIEN CHOU ; Lin H.-C.; YEE-CHUN CHEN ; WOEI TSAY ; JIH-LUH TANG ; SHAN-CHWEN CHANG ; HWEI-FANG TIEN | PLoS ONE | 44 | 39 | |
2015 | Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia | YIN-KAI CHEN ; HSIN-AN HOU ; JIH-LUH TANG ; Jhuang J.-Y.; Lai Y.-J.; Lee M.-C.; Kuo Y.-Y.; WEN-CHIEN CHOU ; Liu C.-Y.; CHUNG-WU LIN ; Chuang S.-S.; Chen, Chien-Yuan ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | PLoS ONE | 7 | 4 | |
2008 | Clinical characteristics and treatment response of Hodgkin's lymphoma in Taiwan | SHANG-JU WU ; Chen, Chien-Yuan ; Su I.-J.; JIH-LUH TANG ; WEN-CHIEN CHOU ; BOR-SHENG KO ; Huang S.-Y.; MING YAO ; WOEI TSAY ; YAO-CHANG CHEN ; Wang C.-H.; HWEI-FANG TIEN | Journal of the Formosan Medical Association | 7 | 6 | |
2012 | Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001-2010 | Chen, Chien-Yuan ; SHANG-YI HUANG ; WOEI TSAY ; MING YAO ; JIH-LUH TANG ; BOR-SHENG KO ; WEN-CHIEN CHOU ; HWEI-FANG TIEN ; PO-REN HSUEH | International Journal of Antimicrobial Agents | 28 | 22 | |
2013 | Clinical features of patients with infections caused by candida guilliermondii and candida fermentati and antifungal susceptibility of the isolates at a medical centre in taiwan, 2001-10 | Chen, Chien-Yuan ; SHANG-YI HUANG ; JIH-LUH TANG ; WOEI TSAY ; MING YAO ; BOR-SHENG KO ; WEN-CHIEN CHOU ; HWEI-FANG TIEN ; PO-REN HSUEH | Journal of Antimicrobial Chemotherapy | 26 | 25 | |
2012 | The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution | SHANG-JU WU ; Kuo Y.-Y.; HSIN-AN HOU ; Li Y.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Lin C.-T.; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; JIH-LUH TANG ; WOEI TSAY ; HWEI-FANG TIEN | Blood | 123 | 100 | |
2006 | Clinical implications of SOCS1 methylation in myelodysplastic syndrome | SHANG-JU WU ; MING YAO ; WEN-CHIEN CHOU ; JIH-LUH TANG ; Chen, Chien-Yuan ; BOR-SHENG KO ; Huang S.-Y.; WOEI TSAY ; YAO-CHANG CHEN ; MING-CHING SHEN ; Wang C.-H.; Yeh Y.-C.; HWEI-FANG TIEN | British Journal of Haematology | 35 | 29 | |
2014 | Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression | HSIN-AN HOU ; Kuo Y.-Y.; JIH-LUH TANG ; WEN-CHIEN CHOU ; MING YAO ; Lai Y.-J.; CHIEN-CHIN LIN ; Chen, Chien-Yuan ; Liu C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 58 | 54 | |
2013 | Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression | SHANG-JU WU ; JIH-LUH TANG ; Lin C.-T.; Kuo Y.-Y.; Li L.-Y.; Tseng M.-H.; Huang C.-F.; Lai Y.-J.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; HSIN-AN HOU ; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; WOEI TSAY ; HWEI-FANG TIEN | American Journal of Hematology | 57 | 42 | |
2018 | Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome | BOR-SHENG KO ; Wang, Yu-Fen; Li, Jeng-Lin; Li, Chi-Cheng; Weng, Pei-Fang; SZU-CHUN HSU ; HSIN-AN HOU ; HUAI-HSUAN HUANG ; MING YAO ; Lin, Chien-Ting; JIA-HAU LIU ; CHENG-HONG TSAI ; TAI-CHUNG HUANG ; SHANG-JU WU ; SHANG-YI HUANG ; WEN-CHIEN CHOU ; HWEI-FANG TIEN ; Lee, Chi-Chun; JIH-LUH TANG | EBioMedicine | 52 | 45 | |
2022 | A Coarse-to-Fine Pathology Patch Selection for Improving Gene Mutation Prediction in Acute Myeloid Leukemia | Chiu, Chun-Chia; Li, Jeng-Lin; Wang, Yu-Fen; BOR-SHENG KO ; Lee, Chi-Chun | Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference | 1 | 0 | |
2011 | Combination antifungal therapy for disseminated fusariosis in immunocompromised patients: A case report and literature review | Liu J.-Y.; Chen W.-T.; BOR-SHENG KO ; MING YAO ; PO-REN HSUEH ; Hsiao C.-H.; YU-MIN KUO ; YEE-CHUN CHEN | Medical Mycology | 36 | 34 | |
2008 | Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies | TAI-CHUNG HUANG ; BOR-SHENG KO ; JIH-LUH TANG ; CHIUN HSU ; Chen, Chien-Yuan ; WOEI TSAY ; SHANG-YI HUANG ; MING YAO ; YAO-CHANG CHEN ; MING-CHING SHEN ; Wang C.-H.; HWEI-FANG TIEN | Leukemia | 47 | 42 | |
2018 | Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA | FENG-MING TIEN ; HSIN-AN HOU ; JIH-LUH TANG ; Kuo, Yuan-Yeh; Chen, Chien-Yuan ; CHENG-HONG TSAI ; MING YAO ; Lin, Chien-Ting; Li, Chi-Cheng; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; JIA-HAU LIU ; SHENG-CHIEH CHOU ; WOEI TSAY ; Tseng, Mei-Hsuan; Liu, Ming-Chih; Liu, Chia-Wen; LIANG-IN LIN ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Haematologica | 25 | 21 | |
2017 | Cordycepin disrupts leukemia association with mesenchymal stromal cells and eliminates leukemia stem cell activity | Liang S.-M.; Lu Y.-J.; BOR-SHENG KO ; Jan Y.-J.; Shyue S.-K.; Yet S.-F.; Liou J.-Y. | Scientific Reports | 25 | 18 | |
2013 | Cordycepin Regulates GSK-3β/β-Catenin Signaling in Human Leukemia Cells | BOR-SHENG KO ; Lu Y.-J.; Yao W.-L.; Liu T.-A.; Tzean S.-S.; Shen T.-L.; Liou J.-Y. | PLoS ONE | 37 | 36 | |
2019 | Cordycepin suppresses endothelial cell proliferation, migration, angiogenesis, and tumor growth by regulating focal Adhesion Kinase and p53 | Lin Y.-T.; Liang S.-M.; Wu Y.-J.; Wu Y.-J.; Lu Y.-J.; Jan Y.-J.; BOR-SHENG KO ; Chuang Y.-J.; Shyue S.-K.; Kuo C.-C.; Liou J.-Y. | Cancers | 15 | 13 | |
2014 | Cordycepin suppresses integrin/FAK signaling and epithelial-mesenchymal transition in hepatocellular Carcinoma | Yao W.-L.; BOR-SHENG KO ; Liu T.-A.; Liang S.-M.; Liu C.-C.; Lu Y.-J.; Tzean S.-S.; Shen T.-L.; Liou J.-Y. | Anti-Cancer Agents in Medicinal Chemistry | 42 | 36 | |
2020 | Correlative analysis of overall survival with clinical characteristics in 127 patients with mantle cell lymphoma: a multi-institutional cohort in Taiwan | Wang, Yu-Hung; SHAN-CHI YU ; BOR-SHENG KO ; YI-TSUNG YANG ; MING YAO ; JIH-LUH TANG ; TAI-CHUNG HUANG | International journal of hematology | 3 | 3 | |